Simon Godfrey, investment specialist, Asian equities ex-Japan at Fortis Investments, is overweight on China. CNBC's Lisa Oake & Rebecca Meehan find out why. He also reveals how he is investing there.
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.
Heinz profit fell 16 percent, but the company beat analyst estimates on emerging-market growth. William Johnson, chairman and CEO of Heinz, talks to CNBC.